{"title":"卡维地洛在同等剂量下对心力衰竭患者并不优于美托洛尔","authors":"A. Gorman","doi":"10.22237/CRP/1567555680","DOIUrl":null,"url":null,"abstract":"<p>A critical appraisal and clinical application of Lazarus DL, Jackevicius CA, Behlouli H, et al. Population-Based Analysis of Class Effect of β Blockers in Heart Failure. <em>The American Journal of Cardiology </em>2011;107(8):1196-1202. doi: <a href=\"https://doi.org/10.1016/j.amjcard.2010.12.017\">10.1016/j.amjcard.2010.12.017</a>.</p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":"44 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Carvedilol is not superior to metoprolol for heart failure patients when given at equivalent doses\",\"authors\":\"A. Gorman\",\"doi\":\"10.22237/CRP/1567555680\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A critical appraisal and clinical application of Lazarus DL, Jackevicius CA, Behlouli H, et al. Population-Based Analysis of Class Effect of β Blockers in Heart Failure. <em>The American Journal of Cardiology </em>2011;107(8):1196-1202. doi: <a href=\\\"https://doi.org/10.1016/j.amjcard.2010.12.017\\\">10.1016/j.amjcard.2010.12.017</a>.</p>\",\"PeriodicalId\":10422,\"journal\":{\"name\":\"Clinical Research In Practice: The Journal of Team Hippocrates\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Research In Practice: The Journal of Team Hippocrates\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22237/CRP/1567555680\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research In Practice: The Journal of Team Hippocrates","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22237/CRP/1567555680","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
Lazarus DL, Jackevicius CA, Behlouli H等的关键性评价及临床应用。β受体阻滞剂治疗心力衰竭的人群效应分析。中华心血管病杂志(英文版);2011;37(8):1196-1202。doi: 10.1016 / j.amjcard.2010.12.017。
Carvedilol is not superior to metoprolol for heart failure patients when given at equivalent doses
A critical appraisal and clinical application of Lazarus DL, Jackevicius CA, Behlouli H, et al. Population-Based Analysis of Class Effect of β Blockers in Heart Failure. The American Journal of Cardiology 2011;107(8):1196-1202. doi: 10.1016/j.amjcard.2010.12.017.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
